We are live on
!
Find out more
PP
Paloma Partners Portfolio holdings
AUM
$510M
1-Year Est. Return
286.05%
This Fund
S&P 500
This Quarter
Est. Return
+3.59%
1 Year Est. Return
+286.05%
3 Year Est. Return
+321.92%
5 Year Est. Return
+284.54%
10 Year Est. Return
+855.7%
AUM
$10.2B
AUM Growth
+$2.21B
(+28%)
Cap. Flow
+$1.91B
Cap. Flow
% of AUM
18.7%
Top 10 Holdings %
Top 10 Hldgs %
42.15%
Holding
2,326
New
523
Increased
761
Reduced
552
Closed
381
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$88.6M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$55.2M |
| 3 |
Amazon
AMZN
|
+$50.7M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$50.4M |
| 5 |
Apple
AAPL
|
+$27.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
KLA
KLAC
|
+$30.4M |
| 2 |
Wells Fargo
WFC
|
+$18.1M |
| 3 |
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
|
+$13.9M |
| 4 |
STJ
St Jude Medical
STJ
|
+$13.5M |
| 5 |
LNKD
LinkedIn Corporation
LNKD
|
+$13.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 4.46% |
| 2 | Industrials | 3.74% |
| 3 | Financials | 3.69% |
| 4 | Healthcare | 3.55% |
| 5 | Technology | 3.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1676
Antero Resources
AR
$10.5B
| $308K | ﹤0.01% |
13,004
-16,064
| -55% | -$412K |
|
|
DRNA
1677
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $308K | ﹤0.01% |
+106,869
| New | +$380K |
|
1678
RPC Inc
RES
$1.21B
| $306K | ﹤0.01% |
+15,483
| New | +$290K |
|
|
TWNKW
1679
DELISTED
Hostess Brands, Inc. Warrants
TWNKW
| $305K | ﹤0.01% |
+175,412
| New | +$302K |
|
1680
Crown Holdings
CCK
$12.9B
| $301K | ﹤0.01% |
5,721
-337
| -6% | -$18.2K |
|
1681
Energizer
ENR
$1.44B
| $299K | ﹤0.01% |
+6,705
| New | +$306K |
|
1682
CALL
Abercrombie & Fitch
ANF
$4.41B
| $298K | ﹤0.01% |
24,800
-200
| -0.8% | -$2.97K |
|
|
1683
PUT
Abercrombie & Fitch
ANF
$4.41B
| $298K | ﹤0.01% |
24,800
-200
| -0.8% | -$2.97K |
|
1684
Photronics
PLAB
$1.76B
| $297K | ﹤0.01% |
+26,266
| New | +$276K |
|
1685
Copart
CPRT
$27.6B
| $296K | ﹤0.01% |
42,776
-254,144
| -86% | -$1.73M |
|
1686
CALL
Dollar General
DG
$27.2B
| $296K | ﹤0.01% |
4,000
-16,000
| -80% | -$1.17M |
|
|
1687
PUT
Dollar General
DG
$27.2B
| $296K | ﹤0.01% |
4,000
-16,000
| -80% | -$1.17M |
|
1688
LXP Industrial Trust
LXP
$3.52B
| $296K | ﹤0.01% |
5,482
+2,322
| +73% | +$118K |
|
1689
Insulet
PODD
$11.4B
| $296K | ﹤0.01% |
7,850
-15,235
| -66% | -$568K |
|
|
TCO
1690
DELISTED
Taubman Centers Inc.
TCO
| $296K | ﹤0.01% |
+4,000
| New | +$290K |
|
1691
Ligand Pharmaceuticals
LGND
$5.96B
| $295K | ﹤0.01% |
+4,660
| New | +$294K |
|
|
RDUS
1692
DELISTED
Radius Recycling
RDUS
| $295K | ﹤0.01% |
11,488
-13,752
| -54% | -$354K |
|
1693
Sunstone Hotel Investors
SHO
$2.2B
| $295K | ﹤0.01% |
+19,328
| New | +$270K |
|
1694
Mativ Holdings
MATV
$455M
| $294K | ﹤0.01% |
6,454
-9,108
| -59% | -$370K |
|
1695
McEwen Inc
MUX
$1.04B
| $293K | ﹤0.01% |
+10,056
| New | +$311K |
|
1696
ONE Gas
OGS
$5.02B
| $292K | ﹤0.01% |
4,561
-6,859
| -60% | -$417K |
|
1697
PayPal
PYPL
$49.5B
| $291K | ﹤0.01% |
7,375
-12,172
| -62% | -$489K |
|
|
NSR
1698
DELISTED
Neustar Inc
NSR
| $291K | ﹤0.01% |
8,700
-400
| -4% | -$10.6K |
|
1699
Banco Bilbao Vizcaya Argentaria
BBVA
$147B
| $290K | ﹤0.01% |
+43,575
| New | +$281K |
|
1700
Buckle
BKE
$2.25B
| $290K | ﹤0.01% |
+12,721
| New | +$293K |
|
Similar funds
JF
PWMG
NIEF
HIM
MCA
OA
MC
CTAF
Paloma Partners's Q4 2016 Portfolio in Review
As of Q4 2016, Paloma Partners held 2,326 positions worth $10.2B, up 28% from $7.99B the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Paloma Partners deployed $1.91B of net new capital in Q4 2016, opening 523 new positions and adding to 761 existing holdings. Its largest new stake was NXP Semiconductors: 253,000 shares worth $24.8M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 4.5% of assets, up from 3.4% a quarter earlier, followed by Industrials and Financials.
On the sell side, the largest reduction was KLA, an estimated $30.4M trimmed.
- Paloma Partners's largest Q4 2016 buy was NXP Semiconductors: 253,000 shares worth $24.8M.
- Paloma Partners added most to Biogen in Q4 2016, an estimated $88.6M increase.
- Paloma Partners's biggest Q4 2016 reduction was KLA, cutting an estimated $30.4M.
- Paloma Partners fully exited St Jude Medical in Q4 2016, selling an estimated $13.5M.
- Paloma Partners's ten largest holdings make up 42% of its $10.2B portfolio in Q4 2016.
- Paloma Partners opened 523 new positions and closed 381 in Q4 2016.
- Paloma Partners's portfolio value rose 28% quarter-over-quarter to $10.2B.
Based on Paloma Partners's 13F filing for Q4 2016, filed 14 Feb 2017.